The exact scope is customized. A typical engagement can include compliance assessment, registration/listing review, ITACS entry-status monitoring, requested-document coordination, Notice of FDA Action review, examination or sample coordination, food-import requirements such as Prior Notice or FSVP when applicable, labeling/documentation review, and ongoing regulatory planning.

No. FDA does not require an importer or manufacturer to hire a private FDA consultant or shipment-monitoring company. Businesses remain responsible for the FDA requirements that apply to their products, facilities, and imports; a consultant is an optional professional resource for managing those requirements.

For covered entries, monitoring can include FDA entry and line status available through ITACS, document-request status, examination or sampling status, estimated FDA laboratory completion dates when available, Notices of FDA Action, and information coordinated with the customs broker, filer, warehouse, laboratory, importer, or foreign supplier.

No. FDA states that PREDICT scores are not released to customs brokers, entry filers, importers, or the general public. PREDICT is an internal FDA screening tool. We monitor the FDA entry status and communications that are available to the import trade rather than claiming access to a confidential PREDICT score.

PREDICT stands for Predictive Risk-based Evaluation for Dynamic Import Compliance Targeting. FDA uses it as a risk-based analytics tool to electronically screen regulated shipments imported or offered for import into the United States.

ITACS is FDA's Import Trade Auxiliary Communication System. It allows the import trade to check FDA entry status, submit entry documentation, submit goods-availability information for lines selected for examination, and view estimated laboratory completion dates for sampled lines.

At minimum, shipment monitoring normally requires the CBP entry number and enough information to identify the shipment and responsible parties. Depending on the issue, we may also need commercial invoices, bill of lading or airway bill, entry documents, product labels, registration/listing information, Prior Notice confirmation, FSVP records, certificates of analysis, intended-use information, or other documents.

No. No consultant, customs broker, laboratory, or monitoring company can guarantee an FDA May Proceed decision. FDA retains authority to review, examine, sample, detain, refuse, or otherwise act on an import based on the applicable law and the facts of the entry.

It cannot guarantee that FDA will not hold, examine, sample, detain, or refuse a shipment. Monitoring can help identify available status changes earlier, organize requested information, reduce internal communication delays, and support a timely response.

FDA may request documents when admissibility cannot be verified from electronic entry data. ITACS is FDA's preferred method for receiving entry documents. The importer, customs broker, entry filer, or another responsible party can submit documents through ITACS.

FDA states that failure to provide requested entry documentation in a timely manner may result in a delay in processing the entry. The appropriate response time also depends on the specific FDA notice, status, or communication.

Yes. We can help coordinate the regulatory side of the process, including reviewing the FDA status, organizing goods-availability information, coordinating with the warehouse and sampler or laboratory, and tracking status information available through ITACS. FDA controls its own examination and sampling decisions.

Yes. We can review the Notice of FDA Action, identify the stated basis and deadlines, organize relevant records or testing, coordinate with laboratories or other specialists when needed, and help the responsible party prepare a response strategy. The specific options depend on the detention.

Yes. We can review the refusal and related entry history, identify the compliance issue, and help determine next steps. Exportation, destruction, reconditioning, future-entry corrections, or other actions may involve FDA, CBP, the customs broker, legal counsel, and other parties depending on the case.

FDA Import Alerts are guidance to FDA personnel identifying products, firms, or countries that may be subject to detention without physical examination (DWPE). When a product subject to DWPE is offered for import, it can be detained without FDA first physically examining the shipment.

Yes, when a removal pathway is available. We can review the specific Import Alert guidance, entry history, underlying violation, corrective actions, testing or documentation needs, and the type of evidence FDA identifies as relevant. The requirements vary by Import Alert and case.

No. Some Import Alerts or FDA practices may look for a history of compliant entries, but there is no universal rule that every Import Alert requires exactly five shipments. The guidance section of the specific Import Alert and the facts of the case should control the strategy.

A customs broker focuses on CBP customs-entry functions such as classification, value, duties, bonds, and transmission of entry data. An FDA consultant focuses on FDA regulatory requirements, documentation, registrations/listings, entry-status interpretation, and FDA compliance strategy. The roles often work together.

Yes. Depending on the situation, a customs broker or entry filer may submit FDA data and documents. FDA's ITACS guidance states that entry documents can be submitted by the importer, customs broker or entry filer, or another responsible party. Whether the broker provides broader regulatory consulting is a business and scope question.

ACE is CBP's electronic trade system used for entry transmission. We can coordinate with the customs broker or filer and review entry information made available to us, but we do not represent that we have independent access to a client's broker systems unless access or data is specifically provided.

No. We can support FDA-regulated imports involving food and beverages, dietary supplements, cosmetics, drugs, medical devices, animal food and feed, and other FDA-regulated products. The legal requirements and monitoring scope differ by category.

Prior Notice is required for imported food that is subject to FDA's Prior Notice regulation, including animal food, unless an exemption applies. The filing deadline depends on the mode of transportation, and international mail has a separate timing rule.

No. Monitoring does not replace Prior Notice. If the imported food is subject to Prior Notice, the filing must still be submitted and confirmed within the applicable regulatory timeframe.

No. Monitoring and FSVP are separate. When an importer and food are subject to FSVP, the FSVP importer must comply with the applicable supplier-evaluation, verification, recordkeeping, and related requirements regardless of whether shipments are being monitored.

No. FDA states that entities identified as FSVP importers may not be the same entities that serve as importers of record for CBP purposes. The FSVP importer must be determined under FDA's FSVP definition.

Yes, if the engagement includes those entries and we receive the entry number and required shipment information. Amazon fulfillment does not change FDA's import requirements, and Amazon is not a substitute for the importer, customs broker, FSVP importer, or other regulated party where those roles apply.

Yes. Pre-import review can include labels, ingredient declarations, claims, registration/listing information, FSVP records, Prior Notice information, certificates, intended-use information, and other documents relevant to the product and agreed scope.

Response timing depends on the urgency, the service agreement, when the communication is received, and the deadline stated by FDA. Our typical initial response target for routine client inquiries is 24–48 hours, while urgent FDA import matters are triaged based on the actual deadline and circumstances.

Pricing is custom. The quote depends on the FDA product category, number of facilities and products, shipment volume, frequency of monitoring, regulatory complexity, risk history, and whether services such as registration maintenance, FSVP, labeling, detention support, or Import Alert work are included.

FDA does not charge a government fee for hiring a private consulting or shipment-monitoring service. However, separate FDA programs can have their own statutory user fees or government fees; those should be distinguished from professional consulting fees.

Yes. Those services can be included in a customized scope when they apply. The quote should identify exactly which services and shipment volume are covered rather than assuming every importer needs the same package.

Yes. We can work with foreign manufacturers on U.S. FDA compliance and coordinate with their U.S. importer, U.S. Agent, FSVP importer, customs broker, distributor, laboratory, or other parties as appropriate. The foreign manufacturer is not automatically the party responsible for every U.S. importer obligation.

Food Facility Registration information is not a public registration database. Verification generally requires access to the relevant FDA Industry Systems account or registration records. We can review the information supplied by the facility and assist with account or registration issues within the service scope.

No. A consultant can provide regulatory analysis, filing and documentation support, monitoring, and recommendations, but the regulated business remains responsible for the accuracy of its information and for compliance with the laws and regulations that apply to it.